Cooley, Goodwin Procter and Gunderson Dettmer Stough Villeneuve Franklin & Hachigian advised Arsenal Biosciences on the transaction. Arsenal Biosciences (ArsenalBio) announced raising $325 million in Series...
You must be a Standard 1 Year member to access this content.
Veirano Advogados, Cooley and Ogier advised BASF VC, while BZCP advised Grão Direto on the transaction. BASF and Grão Direto announced a partnership in the Brazilian...
You must be a Standard 1 Year member to access this content.
Cooley advised Cellares on the fundraising. Cellares has secured $255 million in Series C funding led by new investor Koch Disruptive Technologies. In connection with the...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented Genesis Therapeutics in the fundraising, and Cooley represented Andreessen Horowitz (a16z) Bio + Health Tech Investments. Genesis Therapeutics announced that it has...
You must be a Standard 1 Year member to access this content.
Cooley advised SoundHound AI on the deal. SoundHound AI, a leader in voice artificial intelligence, announced the closing of a new $125 million loan facility from...
You must be a Standard 1 Year member to access this content.
O’Melveny advised Acceldata on the deal while Cooley advised Sanabil. Acceldata, the California-based market leader in data observability, announced its US$50 million Series C funding round. The...
You must be a Standard 1 Year member to access this content.
Foley & Lardner LLP represented Riverwood Capital on the deal while Cooley advised Sanabil. O’Melveny advised Alation. Riverwood Capital, a technology-focused growth equity fund, acted as an...
You must be a Standard 1 Year member to access this content.
Koley and Jessen advised Traive, while Veirano Advogados and Cooley advised BASF VC on the deal. Traive closed its Pre-Series B investment round of US$10 million led...
You must be a Standard 1 Year member to access this content.
Gunderson Dettmer, Veirano Advogados and Conyers, Dill & Pearman advised NG CASH, while BZCP Advogados and Cooley advised A16Z in the transaction. NG.CASH, a Brazil-based fintech...
You must be a Standard 1 Year member to access this content.
Cooley advised Kriya Therapeutics on the deal. Kriya Therapeutics, a fully integrated gene therapy company pioneering novel technologies and therapeutics, announced its $270 Million Series C financing...
You must be a Standard 1 Year member to access this content.
Cooley advised Abnormal Security on the deal. Abnormal Security, a leading artificial intelligence-based cloud-native email security platform, announced its $210 million Series C financing round, which...
You must be a Standard 1 Year member to access this content.
Cooley advised AN2 Therapeutics, while Davis Polk advised the representatives of the several underwriters in the offering. AN2 Therapeutics, Inc. announced its upsized initial public offering of...
You must be a Standard 1 Year member to access this content.
